PRESS RELEASE published on 10/22/2025 at 12:05, 1 year ago Cambrex Unveils $120 Million Investment to Expand API Manufacturing and Strengthen U.S. Drug Supply Resilience Cambrex announces $120 million investment to expand API manufacturing in the U.S., strengthening drug supply resilience and supporting reshoring initiatives. The investment will increase manufacturing capacity by 40% Pharmaceutical Industry Investment API Manufacturing Cambrex Drug Supply Resilience
Published on 10/30/2026 at 23:35, 18 hours 2 minutes ago Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 18 hours 7 minutes ago Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 20:47, 20 hours 50 minutes ago CoTec Holdings Corp. Comments on Share Trading
Published on 10/30/2026 at 19:00, 22 hours 37 minutes ago Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 1 day 2 hours ago Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Published on 10/31/2026 at 16:35, 1 hour 2 minutes ago SKYWORTH Solar Announces Global Launch of Solavita as a Smart Microgrid Brand
Published on 10/30/2026 at 22:49, 18 hours 48 minutes ago EQS-Adhoc: STRATEC SELLS LOSS-MAKING BUSINESS, RECOGNIZES IMPAIRMENTS, AND AMENDS GUIDANCE
Published on 10/30/2026 at 23:00, 18 hours 37 minutes ago BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 23:00, 18 hours 37 minutes ago Biophytis publie les résultats du premier semestre 2026 et fait le point sur sa stratégie
